DrugPatentWatch Database Preview
Drugs in Development Information for Trehalose-6-Phosphate
» See Plans and Pricing
What is the drug development status for Trehalose-6-Phosphate?
Trehalose-6-Phosphate is an investigational drug.
There have been 9 clinical trials for Trehalose-6-Phosphate.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Macular Edema, Depressive Disorder, and Muscular Dystrophies. The leading clinical trial sponsors are Bioblast Pharma Ltd., Mashhad University of Medical Sciences, and Samsung Medical Center.
There are fifteen US patents protecting this investigational drug and eighty-six international patents.
Summary for Trehalose-6-Phosphate
| US Patents | 15 |
| International Patents | 86 |
| US Patent Applications | 26 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 11 |
| Clinical Trial Progress | Phase 2 (2016-06-01) |
| Vendors | 5 |
Recent Clinical Trials for Trehalose-6-Phosphate
| Title | Sponsor | Phase |
|---|---|---|
| Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE) | Mashhad University of Medical Sciences | Phase 1 |
| Inflammation Reduction by TREhalose AdminisTration | Mashhad Razavi Hospital | Phase 2 |
| Inflammation Reduction by TREhalose AdminisTration | National Institute for Medical Research Development | Phase 2 |
Clinical Trial Summary for Trehalose-6-Phosphate
Top disease conditions for Trehalose-6-Phosphate
Top clinical trial sponsors for Trehalose-6-Phosphate
US Patents for Trehalose-6-Phosphate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Trehalose-6-Phosphate | Start Trial | Modified gram positive bacteria and uses thereof | INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) | Start Trial |
| Trehalose-6-Phosphate | Start Trial | Processes of producing fermentation products | NOVOZYMES A/S (Bagsvaerd, DK) | Start Trial |
| Trehalose-6-Phosphate | Start Trial | Modified gram positive bacteria and uses thereof | INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) | Start Trial |
| Trehalose-6-Phosphate | Start Trial | Production of trehalose in plants | Mogen International NV (Leiden, NL) | Start Trial |
| Trehalose-6-Phosphate | Start Trial | OtsA gene encoding trehalose-6-phosphate synthase from a coryneform bacterium | Ajinomoto Co. Inc. (Tokyo, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Trehalose-6-Phosphate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Trehalose-6-Phosphate | Denmark | DK2758512 | 2031-09-23 | Start Trial |
| Trehalose-6-Phosphate | European Patent Office | EP2758512 | 2031-09-23 | Start Trial |
| Trehalose-6-Phosphate | Spain | ES2676707 | 2031-09-23 | Start Trial |
| Trehalose-6-Phosphate | Hungary | HUE038830 | 2031-09-23 | Start Trial |
| Trehalose-6-Phosphate | Japan | JP2014526266 | 2031-09-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
